Phenytek Capsule, Extended Release
Product Images NDC 0378-3750

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Phenytek (NDC 0378-3750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Phenytek Capsules 200 mg Bottle Label (Image 01)

This is the medication information for Phenytek® capsule, available in a dosage of 200mg, and may be adjusted to max 300mg depending on individual needs. The package includes prescribing information and the medication guide that should be given to patients with each dispense. The medication should be stored in a tightly closed container at 20° to 25°C and protected from light and moisture. It should also be kept out of the reach of children.*

FDA Label Image

Phenytek Capsules 300 mg Bottle Label (Image 02)

Phenytoin sodium capsules, USP, are used for pediatric patients with an initial dosage of 5 mg/kg daily, with a maximum daily dosage of 300 mg. These capsules are child-resistant and come in a container defined by the USP. Each capsule contains 300 mg of phenytoin sodium, and the medication should be kept out of reach of children. The capsules should be stored at 20° to 25°C (68° to 77°F), and a medication guide should be provided to each patient. The manufacturer is Morgantown and the product is sold in packages of 30 capsules.*

FDA Label Image

Phenytoin Structural Formula (Image 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.